These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35753639)

  • 21. A clinical prediction model to determine outcomes in patients with cervical spondylotic myelopathy undergoing surgical treatment: data from the prospective, multi-center AOSpine North America study.
    Tetreault LA; Kopjar B; Vaccaro A; Yoon ST; Arnold PM; Massicotte EM; Fehlings MG
    J Bone Joint Surg Am; 2013 Sep; 95(18):1659-66. PubMed ID: 24048553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient phenotypes associated with outcome following surgery for mild degenerative cervical myelopathy: a principal component regression analysis.
    Badhiwala JH; Witiw CD; Nassiri F; Jaja BNR; Akbar MA; Mansouri A; Merali Z; Ibrahim GM; Wilson JR; Fehlings MG
    Spine J; 2018 Dec; 18(12):2220-2231. PubMed ID: 29746963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A clinical prediction model to assess surgical outcome in patients with cervical spondylotic myelopathy: internal and external validations using the prospective multicenter AOSpine North American and international datasets of 743 patients.
    Tetreault LA; Côté P; Kopjar B; Arnold P; Fehlings MG;
    Spine J; 2015 Mar; 15(3):388-97. PubMed ID: 25549860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients with degenerative cervical myelopathy have signs of blood spinal cord barrier disruption, and its magnitude correlates with myelopathy severity: a prospective comparative cohort study.
    Blume C; Geiger MF; Brandenburg LO; Müller M; Mainz V; Kalder J; Albanna W; Clusmann H; Mueller CA
    Eur Spine J; 2020 May; 29(5):986-993. PubMed ID: 31982957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in clinical outcomes between traumatic cervical myelopathy and degenerative cervical myelopathy: A comparative study of cervical spinal cord injury without major bone injury and cervical spondylotic myelopathy.
    Machino M; Ando K; Kobayashi K; Morozumi M; Tanaka S; Ito K; Kato F; Ishiguro N; Imagama S
    J Clin Neurosci; 2019 Dec; 70():127-131. PubMed ID: 31427237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does Magnetic Resonance Imaging Improve the Predictive Performance of a Validated Clinical Prediction Rule Developed to Evaluate Surgical Outcome in Patients With Degenerative Cervical Myelopathy?
    Nouri A; Tetreault L; Côté P; Zamorano JJ; Dalzell K; Fehlings MG
    Spine (Phila Pa 1976); 2015 Jul; 40(14):1092-100. PubMed ID: 25893357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of perfusion impairment in degenerative cervical myelopathy beyond the site of cord compression.
    Lebret A; Lévy S; Pfender N; Farshad M; Altorfer FCS; Callot V; Curt A; Freund P; Seif M
    Sci Rep; 2023 Dec; 13(1):22660. PubMed ID: 38114733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Machine learning algorithms for prediction of health-related quality-of-life after surgery for mild degenerative cervical myelopathy.
    Khan O; Badhiwala JH; Witiw CD; Wilson JR; Fehlings MG
    Spine J; 2021 Oct; 21(10):1659-1669. PubMed ID: 32045708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
    Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
    Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased spinal cord movements in cervical spondylotic myelopathy.
    Vavasour IM; Meyers SM; MacMillan EL; Mädler B; Li DK; Rauscher A; Vertinsky T; Venu V; MacKay AL; Curt A
    Spine J; 2014 Oct; 14(10):2344-54. PubMed ID: 24462810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The changes in systemic monocytes in humans undergoing surgical decompression for degenerative cervical myelopathy may influence clinical neurological recovery.
    Vidal PM; Ulndreaj A; Tetreault L; Hong J; Fehlings MG
    J Neuroimmunol; 2019 Nov; 336():577024. PubMed ID: 31450156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgery for Degenerative Cervical Myelopathy: What Really Counts?
    Gembruch O; Jabbarli R; Rashidi A; Chihi M; Hetze S; Barthel L; Toplak A; El Hindy N; Sure U; Dammann P; Özkan N
    Spine (Phila Pa 1976); 2021 Mar; 46(5):294-299. PubMed ID: 33065693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of changes in spinal cord signal intensity on magnetic resonance imaging in patients with cervical compressive myelopathy.
    Uchida K; Nakajima H; Takeura N; Yayama T; Guerrero AR; Yoshida A; Sakamoto T; Honjoh K; Baba H
    Spine J; 2014 Aug; 14(8):1601-10. PubMed ID: 24411833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylated neurofilament subunit NF-H becomes elevated in the cerebrospinal fluid of patients with acutely worsening symptoms of compression myelopathy.
    Takahashi H; Aoki Y; Nakajima A; Sonobe M; Terajima F; Saito M; Taniguchi S; Yamada M; Watanabe F; Furuya T; Koda M; Yamazaki M; Takahashi K; Nakagawa K
    J Clin Neurosci; 2014 Dec; 21(12):2175-8. PubMed ID: 25065845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced MRI metrics improve the prediction of baseline disease severity for individuals with degenerative cervical myelopathy.
    Al-Shawwa A; Ost K; Anderson D; Cho N; Evaniew N; Jacobs WB; Martin AR; Gaekwad R; Tripathy S; Bouchard J; Casha S; Cho R; duPlessis S; Lewkonia P; Nicholls F; Salo PT; Soroceanu A; Swamy G; Thomas KC; Yang MMH; Cohen-Adad J; Cadotte DW
    Spine J; 2024 Sep; 24(9):1605-1614. PubMed ID: 38679077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting Injury Severity and Neurological Recovery after Acute Cervical Spinal Cord Injury: A Comparison of Cerebrospinal Fluid and Magnetic Resonance Imaging Biomarkers.
    Dalkilic T; Fallah N; Noonan VK; Salimi Elizei S; Dong K; Belanger L; Ritchie L; Tsang A; Bourassa-Moreau E; Heran MKS; Paquette SJ; Ailon T; Dea N; Street J; Fisher CG; Dvorak MF; Kwon BK
    J Neurotrauma; 2018 Feb; 35(3):435-445. PubMed ID: 29037121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional cortical reorganization in cases of cervical spondylotic myelopathy and changes associated with surgery.
    Bhagavatula ID; Shukla D; Sadashiva N; Saligoudar P; Prasad C; Bhat DI
    Neurosurg Focus; 2016 Jun; 40(6):E2. PubMed ID: 27246485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of Return to Normal Neurological Function After Surgery for Moderate and Severe Degenerative Cervical Myelopathy: An Analysis of A Global AOSpine Cohort of Patients.
    De la Garza Ramos R; Nouri A; Nakhla J; Echt M; Gelfand Y; Patel SK; Nasser R; Cheng JS; Yassari R; Fehlings MG
    Neurosurgery; 2019 Nov; 85(5):E917-E923. PubMed ID: 31144725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of the cervical myelopathy severity index: a new patient reported outcome measure to quantify impairments and functional limitations.
    Malhotra AK; He Y; Harrington EM; Jaja BNR; Zhu MP; Shakil H; Dea N; Weber MH; Attabib N; Phan P; Rampersaud YR; Paquet J; Jacobs WB; Cadotte DW; Christie SD; Nataraj A; Bailey CS; Johnson M; Fisher C; Hall H; Manson N; Thomas K; Ginsberg HJ; Fehlings MG; Witiw CD; Davis AM; Wilson JR
    Spine J; 2024 Mar; 24(3):424-434. PubMed ID: 37918571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cervical spondylotic myelopathy: surgical results and factors affecting prognosis.
    Naderi S; Ozgen S; Pamir MN; Ozek MM; Erzen C
    Neurosurgery; 1998 Jul; 43(1):43-9; discussion 49-50. PubMed ID: 9657187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.